These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12789219)

  • 21. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S; Zaher C
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic impact of migraine: an analysis of direct and indirect costs.
    Edmeads J; Mackell JA
    Headache; 2002 Jun; 42(6):501-9. PubMed ID: 12167138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey.
    Sullivan PW; Ghushchyan VH; Slejko JF; Belozeroff V; Globe DR; Lin SL
    J Allergy Clin Immunol; 2011 Feb; 127(2):363-369.e1-3. PubMed ID: 21281868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-level medical and absenteeism cost of asthma in the United States.
    Nurmagambetov T; Khavjou O; Murphy L; Orenstein D
    J Asthma; 2017 May; 54(4):357-370. PubMed ID: 27715355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic consequences of irritable bowel syndrome: a US employer perspective.
    Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
    Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
    Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
    Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What are the health and socioeconomic impacts of allergic respiratory disease in Tasmania?
    Borchers-Arriagada N; Jones PJ; Palmer AJ; Bereznicki B; Cooling N; Davies JM; Johnston FH
    Aust Health Rev; 2021 Jun; 45(3):281-289. PubMed ID: 33789077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Costs due to asthma medical care in a group of children from northeastern Mexico].
    Gallardo Martínez G; Arias Cruz A; González Díaz SN; Galindo Rodríguez G
    Rev Alerg Mex; 2007; 54(3):82-5. PubMed ID: 17849793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct and indirect costs of paediatric asthma in the UK: a cost analysis.
    Kennedy CT; Scotland GS; Cotton S; Turner SW
    Arch Dis Child; 2024 Aug; 109(9):724-729. PubMed ID: 38802171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cost of Asthma Treatment in Phramongkutlao Hospital: Population-Based Study in Adults.
    Boonpiyathad T; Yimsawad S; Sangasapaviriya A
    J Med Assoc Thai; 2016 Jan; 99(1):51-7. PubMed ID: 27455824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States.
    Song HJ; Blake KV; Wilson DL; Winterstein AG; Park H
    J Asthma Allergy; 2020; 13():545-555. PubMed ID: 33149626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study].
    Marcellusi A; Viti R; Incorvaia C; Mennini FS
    Recenti Prog Med; 2015 Oct; 106(10):517-27. PubMed ID: 26442978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The socioeconomic impact of narcolepsy.
    Dodel R; Peter H; Walbert T; Spottke A; Noelker C; Berger K; Siebert U; Oertel WH; Kesper K; Becker HF; Mayer G
    Sleep; 2004 Sep; 27(6):1123-8. PubMed ID: 15532206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of diabetes on workforce participation: results from a national household sample.
    Vijan S; Hayward RA; Langa KM
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1653-69. PubMed ID: 15533180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The direct cost of treating bronchial asthma in a teaching hospital in Malaysia.
    Chan PW; Hussain S; Ghani NH; Debruyne JA; Liam CK
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):600-3. PubMed ID: 12693597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-benefit analysis of childhood asthma management through school-based clinic programs.
    Tai T; Bame SI
    J Community Health; 2011 Apr; 36(2):253-60. PubMed ID: 20803167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of asthma in New South Wales.
    Mellis CM; Peat JK; Bauman AE; Woolcock AJ
    Med J Aust; 1991 Oct; 155(8):522-8. PubMed ID: 1943931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost savings from intravenous immunoglobulin manufactured from chromotography/caprylate (IGIV-C) in persons with primary humoral immunodeficiency disorder.
    Mahadevia PJ; Strell J; Kunaprayoon D; Gelfand E
    Value Health; 2005; 8(4):488-94. PubMed ID: 16091026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.